Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma
Xiaochen Wang(First Affiliated Hospital Zhejiang University), LU Xiao-jie(Affiliated Hospital of Youjiang Medical University for Nationalities), Haiyuan Shen(Anhui Medical University), Jianchu Wang(Affiliated Hospital of Youjiang Medical University for Nationalities), Zongjiang Luo(Affiliated Hospital of Youjiang Medical University for Nationalities)
Cited by 24
Related Papers
TOX promotes the exhaustion of antitumor CD8+ T cells by preventing PD1 degradation in hepatocellular carcinoma
|Journal of Hepatology|2019|289
Liver diseases: epidemiology, causes, trends and predictions
|Signal Transduction and Targeted Therapy|2025|205
14-3-3ζ delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumor function of tumor-infiltrating T lymphocytes
|Cell Death and Disease|2018|135
Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma
|Journal of Cancer Research and Therapeutics|2017|98